CA
Polynovo Limited
CALZF · OTC
$0.75 +0.00% (+$0.00)
1M -0.55%
Market Cap $712.8M
P/E Ratio 97.23x
Div. Yield -
ROE 8.82%
Bulios Fair Price
$0.68
9.7% downside
Current Price
$0.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CALZF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
4 /100
Expensive P/E 97.23x
EV/EBITDA 49.99x
P/S 4.97x
Growth
97 /100
Growing Rev. growth 30.05%
Book val. growth 11.47%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 32.70%
Net margin 5.11%
Op. margin 7.28%
Quality
53 /100
Average ROIC 8.86%
ROE 8.82%
ROA 5.54%
Debt
99 /100
Low Debt/Equity 0.19x
Current ratio 2.99x
Int. coverage 11.36x
Stability
33 /100
Unstable Beta 1.38x
Rev. volatility 23.76%
EPS volatility 131.10%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CALZF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Bruce Peatey
Employees
301
Headquarters
Port Melbourne
Upcoming events
02 MAR
Earnings
Upcoming earnings report